Midori Kato-Maeda, MD, MA

UCSF Center for Tuberculosis DEIAB Co-Chair
Associate Professor

I lead the Mycobacterium tuberculosis research laboratory at Zuckerberg San Francisco General Hospital. The first goal of my laboratory is to fundamentally advance molecular diagnostics for pre-XDR and XDR TB by identifying new biomarkers of drug resistance in a rapid and unbiased manner, and by identifying causes that may decrease the efficiency of molecular methods such as the presence of hetero-resistance. The second goal is to determine the contribution of bacterial factors in the transmission and pathogenesis of tuberculosis.

Andrew Kerkhoff, MD, PhD, MS

Assistant Adjunct Professor

Dr. Andew Kerkhoff is a physician-scientist and an Assistant Professor of Medicine in the Division of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General Hospital (ZSFG). His research has two main focuses: (1) He has more than a decade of experience evaluating novel tests and strategies to improve the diagnosis of tuberculosis (TB) in sub-Saharan Africa, with a focus on low-cost, point-of-care tools.

Nevan Krogan, PhD

QBI Director and Professor
Cellular Molecular Pharmacology

My lab at UCSF focuses on developing and applying quantitative, systematic proteomic and genetic approaches to study complex biological and biomedical problems. At present time, my group is focused on studying cancer, infectious disease, including tuberculosis, and psychiatric disorders.

Krogen Lab:

Ada Kwan, PhD, MHS

Postdoctoral Scholar

I am a health and development economist working with Drs. Priya Shete and Adithya Cattamanchi in the Division of Pulmonary & Critical Care and with Dr. Brie Williams and the Amend team in the Center for Vulnerable Populations. My research focuses on evaluating health systems interventions and programs, often ones related to measuring quality and equity of care delivery. Methodologically, I utilize randomization, quasi-experiments, and complex surveys, such as simulated standardized patients, to assess the effects and implications of scaling up related health programs.

Chaz Langelier, MD, PhD

Assoc. Professor In Residence

My lab employs metagenomic sequencing technologies to advance understanding of infectious and pulmonary disease pathophysiology, develop new diagnostics based on host and microbe transcriptional profiling, and track the transmission of pathogens during outbreaks.  I am a co-investigator on an NIAID R01-funded study that is employing a novel combination of metagenomic next-generation sequencing coupled with a CRISPR/Cas9-based targeted enrichment method to detect TB and antimicrobial resistance genes in cerebrospinal fluid from patients with suspected TB meningitis while also performing long

Jason Limberis, PhD

Assistant Researcher

My research focusses on the causative agent of tuberculosis, Mycobacterium tuberculosis: I apply a combination of wet work and bioinformatics to investigate genomic and transcriptional associates of drug resistance, clinical outcomes, and patient infectiousness. See for more information.

Tracy Lin, PhD

Associate Adjunct Professor
Institute for Health & Aging

Janice Louie, MPH, MD

Associate Clin Prof Volunteer

 I am the Medical Director of the San Francisco Department of Public Health (SFDPH) Tuberculosis Clinic at Ward 94 located at Zuckerberg San Francisco General Hospital. In addition to overseeing the clinical team in San Francisco, I also have experience working overseas in tuberculosis surveillance. I am board-certified in internal medicine and infectious diseases and continue to consult on infectious diseases at the San Francisco Veterans Administration Medical Center.

Annie Luetkemeyer

Professor of Clinical Medicine

I specialize in HIV/AIDS and have clinical responsibilities including outpatient services at the San Francisco General Hospital HIV clinic as well as inpatient services on the HIV/AIDS, general medicine, and infectious diseases consult services. I direct the HIV Clinical Trials Group at SFGH, which conducts investigator-initiated and industry HIV trials. I am site investigator for the Adult AIDS Clinical Trials Group (ACTG), and my research interests include HIV and TB coinfection, development of novel TB diagnostics, and HIV and viral hepatitis coinfection.

Carina Marquez, MD, MPH

Assoc In Residence Professor

My research focuses on elucidating the drivers of the large latent TB reservoir in East Africa and developing interventions to prevent TB infection and to improve the TB care continuum for HIV-infected and uninfected children and adults living in sub-Saharan Africa. Clinically, I am the Assistant Director of the Infectious Diseases Clinic at ZSFG, and direct the SALUD clinic, a clinic within the Positive Health Practice "Ward 86" at ZSFG, that is dedicated to providing multidisciplinary care to monolingual Spanish-speaking HIV-infected patients.

John Metcalfe, MD, PhD, MPH

Professor In Residence

I have a particular interest in clinical management of multidrug resistant tuberculosis (MDR-TB) in high HIV burden settings in Southern Africa. My research includes the development of non-invasive pharmacokinetic measures to enhance MDR-TB drug development and clinical trials. I am a member of the AIDS Clinical Trials Group TB Transformative Science Group, and have specialized training in epidemiology, statistical prediction, and diagnostic test evaluation. I am a specialty editor for respiratory diseases at PLoS Medicine.

Mike Morimoto

Data Scientist